Post-IPO Equity Biotechnology Companies

Agronomics is an investment business that focuses on the environmentally sustainable prospects within the burgeoning food industry.

FendX Technologies is a technology company developing surface protection products that protect surfaces from pathogen contamination.

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Atlantic Coastal Acquisition Corp. II is a blank check company.

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Biotechnology company that leverages Artificial Intelligence, DNA, microbiome and epigenetic data for alternative health solutions.

ASEP Medical develops a diagnostic assay for the early and rapid diagnosis of sepsis.

BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

Veru is a biopharmaceutical company that specializes in developing novel medicines.